EGFR and esophageal squamous cell carcinoma: Furthermore, our previous studies show that p120ctn down-regulation and EGFR overexpression occurs simultaneously in 67% of human ESCC samples, making this a clinically-relevant condition represented in a majority of ESCC samples24.